A look back can show the way forward for Oklahoma innovationPublished: Tuesday, April 17, 2018 By: Scott Meacham Source: News OK
If you are a regular reader of these columns, and I hope you are, you can tell that I like history. There are the lessons, of course, and the perspective we gain from looking back. And there are the celebratory moments. There's always an “aha” moment in history, although we may not recognize it at the time.
This year, as i2E is celebrating our 20th anniversary, I got to thinking about what we'll be remembered for another 20 years from now.
Over 20 years, it is easy to misplace the details of some of our state's greatest stories. Take Novazyme Pharmaceuticals, founded by William Canfield, MD, PhD, formerly a scientist at the University of Oklahoma Health Sciences Center and taken through a much-heralded exit by CEO John Crowley.
Canfield's research made a breakthrough in the treatment of a rare genetic disorder called Pompe disease. It's a form a muscular dystrophy that happens at birth and later in life and causes muscle weakness that typically leads to death, especially in children.